"ibalizumab" meaning in English

See ibalizumab in All languages combined, or Wiktionary

Noun

Etymology: From [Term?] + -li- (“immunomodulating”) + -zumab (“humanized monoclonal antibody”). Etymology templates: {{af|en||-li-|-zumab|t2=immunomodulating|t3=humanized monoclonal antibody}} [Term?] + -li- (“immunomodulating”) + -zumab (“humanized monoclonal antibody”) Head templates: {{en-noun|-}} ibalizumab (uncountable)
  1. (pharmacology) A nonimmunosuppressive monoclonal antibody being investigated as an HIV entry inhibitor. Wikipedia link: ibalizumab Tags: uncountable Categories (topical): Pharmaceutical drugs

Download JSON data for ibalizumab meaning in English (1.8kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-li-",
        "4": "-zumab",
        "t2": "immunomodulating",
        "t3": "humanized monoclonal antibody"
      },
      "expansion": "[Term?] + -li- (“immunomodulating”) + -zumab (“humanized monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -li- (“immunomodulating”) + -zumab (“humanized monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "ibalizumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -li-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -zumab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A nonimmunosuppressive monoclonal antibody being investigated as an HIV entry inhibitor."
      ],
      "id": "en-ibalizumab-en-noun-gN37t1vf",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "nonimmunosuppressive",
          "nonimmunosuppressive"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "HIV",
          "HIV"
        ],
        [
          "entry",
          "entry"
        ],
        [
          "inhibitor",
          "inhibitor"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A nonimmunosuppressive monoclonal antibody being investigated as an HIV entry inhibitor."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "ibalizumab"
      ]
    }
  ],
  "word": "ibalizumab"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-li-",
        "4": "-zumab",
        "t2": "immunomodulating",
        "t3": "humanized monoclonal antibody"
      },
      "expansion": "[Term?] + -li- (“immunomodulating”) + -zumab (“humanized monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -li- (“immunomodulating”) + -zumab (“humanized monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "ibalizumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English term requests",
        "English terms interfixed with -li-",
        "English terms suffixed with -zumab",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A nonimmunosuppressive monoclonal antibody being investigated as an HIV entry inhibitor."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "nonimmunosuppressive",
          "nonimmunosuppressive"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "HIV",
          "HIV"
        ],
        [
          "entry",
          "entry"
        ],
        [
          "inhibitor",
          "inhibitor"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A nonimmunosuppressive monoclonal antibody being investigated as an HIV entry inhibitor."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "ibalizumab"
      ]
    }
  ],
  "word": "ibalizumab"
}

This page is a part of the kaikki.org machine-readable English dictionary. This dictionary is based on structured data extracted on 2024-06-04 from the enwiktionary dump dated 2024-05-02 using wiktextract (e9e0a99 and db5a844). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.